Genetic Cystinuria Test Price | Lahalak Medical Platform

Identify the underlying genetic cause of recurrent bladder stones through advanced molecular testing of SLC3A1 and SLC7A9 genes, enabling personalized prevention and effective management strategies for cystinuria.

Scientific name: Genetic Screening for Cystinuria (SLC3A1 & SLC7A9)

A specialized molecular test identifying mutations in SLC3A1 and SLC7A9 genes. It diagnoses hereditary cystinuria, a condition causing recurrent bladder and kidney stones, facilitating targeted medical management and prevention.

Genetic Screening for Cystinuria (SLC3A1 & SLC7A9) - Genetic Screening for Recurrent Cystinuria
Service type Genetic laboratory test
Duration 15-20 minutes
Fasting Fasting is not required

Included Services

  • Blood sample collection or buccal swab
  • Sequencing of SLC3A1 and SLC7A9 genes
  • Detailed clinical results report

Medical Service Information

Purpose of the Screening

  • Confirm the diagnosis of hereditary Cystinuria.
  • Identify specific genetic mutations causing recurrent stones.
  • Guide physicians in selecting the most effective preventative medications.
  • Screen family members at risk of inheriting the condition.

Who Should Get Tested?

  • Patients with recurrent bladder or kidney stones.
  • Children or young adults presenting with early-onset stones.
  • Individuals with a known family history of cystinuria.
  • Patients who do not respond to standard stone prevention treatments.

Understanding Results

  • Positive Result: Confirms the presence of a pathogenic mutation.
  • Negative Result: No mutations found in SLC3A1/SLC7A9; further testing may be needed.
  • Clinical Guidance: Provides a basis for personalized diet and drug therapy.

Conditions & Notices

  • Preferably provide previous medical reports regarding urinary stones

Medical services you might also like